Literature DB >> 9542604

Prevalence of allergy in children in relation to prior BCG vaccination and infection with atypical mycobacteria.

I L Strannegård1, L O Larsson, G Wennergren, O Strannegård.   

Abstract

By influence on the Th1/Th2 cell balance, infectious agents may affect the development of atopic allergy. In this study, we investigated whether previous BCG vaccination or infection with atypical mycobacteria might be related to the development of atopic disease. The study, which involved skin testing with mycobacteria and answers to a questionnaire for more than 6000 children in Sweden, revealed a low prevalence of allergy among BCG-vaccinated children who were immigrants or adopted from other countries. Vaccinated children born in Sweden, however, did not have significantly lower allergy prevalence than age-matched, unvaccinated children. Furthermore, the overall frequencies of skin-test reactivity to the atypical mycobacteria M. avium and M. scrofulaceum were higher rather than lower in allergic than in nonallergic children. By contrast, there was a tendency toward a lower frequency of more strongly positive skin reactions (> or = 10 mm) to mycobacteria in allergic than in nonallergic children. These findings do not support the hypothesis that early mycobacterial infections have a suppressive effect on the development of atopic disease. Earlier findings of an apparent association between atopy and lack of previous mycobacterial infection may possibly be explained by a relatively decreased ability of atopic patients to mount strong Th1 cell-mediated immune responses.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9542604     DOI: 10.1111/j.1398-9995.1998.tb03884.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  21 in total

Review 1.  Family size, infection and atopy: the first decade of the "hygiene hypothesis".

Authors:  D P Strachan
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

Review 2.  Epidemiology of allergic rhinitis.

Authors:  R Michael Sly
Journal:  Clin Rev Allergy Immunol       Date:  2002-02       Impact factor: 8.667

Review 3.  Pollution and the immune response: atopic diseases--are we too dirty or too clean?

Authors:  D Diaz-Sanchez
Journal:  Immunology       Date:  2000-09       Impact factor: 7.397

4.  Immunization and symptoms of atopic disease in children: results from the International Study of Asthma and Allergies in Childhood.

Authors:  H R Anderson; J D Poloniecki; D P Strachan; R Beasley; B Björkstén; M I Asher
Journal:  Am J Public Health       Date:  2001-07       Impact factor: 9.308

5.  Timing of routine immunisations and subsequent hay fever risk.

Authors:  S A Bremner; I M Carey; S DeWilde; N Richards; W C Maier; S R Hilton; D P Strachan; D G Cook
Journal:  Arch Dis Child       Date:  2005-06       Impact factor: 3.791

6.  Analysis of recombinant mycobacteria as T helper type 1 vaccines in an allergy challenge model.

Authors:  R Janssen; A Kruisselbrink; L Hoogteijling; J R Lamb; D B Young; J E Thole
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

Review 7.  The potential of Mycobacterium to protect against allergy and asthma.

Authors:  Charles C Obihara; Jan L L Kimpen; Nulda Beyers
Journal:  Curr Allergy Asthma Rep       Date:  2007-06       Impact factor: 4.806

8.  A recombinant BCG vaccine generates a Th1-like response and inhibits IgE synthesis in BALB/c mice.

Authors:  M Kumar; A K Behera; H Matsuse; R F Lockey; S S Mohapatra
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

9.  The effects of Mycobacteria vaccae derivative on allergen-specific responses in children with atopic dermatitis.

Authors:  J A Dunstan; S Brothers; J Bauer; M Hodder; M M Jaksic; M I Asher; S L Prescott
Journal:  Clin Exp Immunol       Date:  2011-03-17       Impact factor: 4.330

Review 10.  Effects of intestinal microflora and the environment on the development of asthma and allergy.

Authors:  Bengt Björkstén
Journal:  Springer Semin Immunopathol       Date:  2003-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.